Related Experiment Video
Updated: Aug 9, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing
Rosa Méndez1, Francisco Ruiz-Cabello, Teresa Rodríguez
1Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nueves, Avda Fuerzas Armadas s/n, 18014, Granada, Spain.
Abstract:
The cytotoxic activity of T cells selects the outgrowth of tumor cells that escape from immune surveillance by different strategies. The different mechanisms that interfere with immune recognition and limit vaccination efficiency are still poorly understood. We analysed six cell lines established from different metastases of melanoma patient UKRV-Mel-20 for specific characteristics known to have an impact on the tumor-T cell interaction: (1) alterations in the HLA class I phenotype, (2) expression of Fas/CD95, and (3) expression of specific cytokines and chemokines. One of the cell lines, UKRV-Mel-20f, exhibited an HLA class I haplotype loss and just this cell line was also characterised by the expression of Fas/CD95 and of relatively high levels of proinflammatory chemokines suggesting that the cytotoxic activity of tumor-infiltrating T cells might have selected the outgrowth of this tumor cell variant. All other cell lines analysed showed no alterations in HLA class I expression, but, in contrast to UKRV-Mel-20f, expressed much lower levels of Fas/CD95 and of proinflammatory chemokines and some of them produced high levels of immunosuppressive TGF-beta1. These results suggest that in patient UKRV-Mel-20, tumor cells interfere with T cell recognition by different strategies which might partially explain why this patient did not have a clinical response to an autologous tumor cell vaccine.
Insights
Tumor cells evade T cell attacks through various immune escape strategies. One melanoma cell line lost HLA class I, expressed Fas/CD95, and secreted chemokines, indicating immune selection.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- T cell cytotoxic activity can select for tumor cells that evade immune surveillance.
- Mechanisms of immune escape and their impact on vaccination efficiency are not fully understood.
- Understanding tumor-T cell interactions is crucial for developing effective cancer therapies.
Purpose of the Study:
- To analyze melanoma cell lines for characteristics influencing tumor-T cell interactions.
- To investigate alterations in HLA class I phenotype, Fas/CD95 expression, and cytokine/chemokine profiles.
- To understand immune escape strategies employed by melanoma cells in patient UKRV-Mel-20.
Main Methods:
- Analysis of six cell lines derived from melanoma patient UKRV-Mel-20 metastases.
- Assessment of HLA class I phenotype, Fas/CD95 expression, and cytokine/chemokine secretion.
- Comparison of immune evasion characteristics between different melanoma cell lines.
Main Results:
- One cell line (UKRV-Mel-20f) showed HLA class I loss, Fas/CD95 expression, and high proinflammatory chemokines.
- This suggests T cell activity selected for this specific tumor cell variant.
- Other cell lines lacked HLA class I alterations but had lower Fas/CD95, lower chemokines, and some produced immunosuppressive TGF-beta1.
Conclusions:
- Melanoma cells in patient UKRV-Mel-20 utilize diverse strategies to interfere with T cell recognition.
- The observed immune escape mechanisms may explain the lack of response to autologous tumor cell vaccination.
- Targeting these specific immune evasion pathways could improve therapeutic outcomes in melanoma.
Related Concept Videos
01:27Tumor Immunotherapy
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...